Interventions: Behavioral: DBT-based Group Skills Training (DBT-GST); Behavioral: CBT-based Group Skills Training (CBT-GST)
Sponsors: Atlas University; Istanbul Medeniyet University
Completed
National survey of teens finds that meaningful relationships can serve as a powerful protective factor against anxiety and depression
New York, NY – A new study from the Child Mind Institute found that nearly half the teens surveyed reported experiencing moderate to severe loneliness, despite being the most digitally connected generation. The study was funded by the Morgan Stanley Alliance for Children’s Mental Health.
Released in recognition of World Mental Health Day on October 10, Building Bridges: Teen Loneliness and Connection asked 1,000 U.S. teens aged 14-17 what connection means to them, where they feel most connected, and who they turn to when they need support. The survey examined connectedness across five domains — family, peers, school, self, and digital environments. The results underscore the importance of feeling a sense of connection during adolescence, finding that teens who experience a stronger sense of belonging report better mental health outcomes.
“We’re currently experiencing a loneliness epidemic that has become an urgent concern, especially among young people,” said Angela Moyer, PsyD, a psychologist in School and Community Programs at the Child Mind Institute. “This study centers teens’ voices, helping us to move beyond identifying the problem and more toward understanding which forms of connection matter most and where families, schools, communities, and policymakers can invest to strengthen teen mental health.”
While past research has examined family, friendships, and school belonging in silos, Building Bridges: Teen Loneliness and Connection was designed to understand how these domains together affect teens’ mental health and pinpoint meaningful opportunities for impact. The findings offer important insights for parents, educators, and communities seeking to strengthen support for young people’s emotional well-being and how to foster in-person experiences.
To read the full Building Bridges: Teen Loneliness and Connection report, click here, and visit childmind.org to learn more.
About Child Mind Institute
The Child Mind Institute is the leading nonprofit dedicated to transforming the lives of children and families experiencing mental health and learning disorders. Since its founding in 2009, the Child Mind Institute has become a global institution reaching millions of families each year through excellence in evidence-based clinical care, renowned educational resources and training, and science to advance the next generation of treatment.
Visit the Child Mind Institute on social media: Instagram, Facebook, X, LinkedIn
For press questions, contact us at childmindinstitute@ssmandl.com or mediaoffice@childmind.org.
The post Child Mind Institute Study Finds Strong Link Between Teen Belonging and Mental Health appeared first on Child Mind Institute.
Background: Mental Health Online, MindSpot, and THIS WAY UP are 3 Australian Government–funded digital mental health services (DMHSs). These services are free for consumers and deliver a range of (depression and anxiety disorder) psychological assessments and interventions using the internet, with or without clinician support. Objective: This study examines the uptake and effectiveness of these services. Methods: We used 3 data sources to examine the performance of the three DMHSs: (1) aggregated routinely collected service data to describe uptake of the services from January 2013 to December 2021, (2) peer-reviewed and gray literature reporting treatment outcomes, and (3) treatment outcome data from one evaluation conducted by Mental Health Online. The second and third data sources were used to analyze the effectiveness of the DMHSs compared to other mental health treatment programs (Australian primary, public, and low-intensity mental health care; UK stepped psychological care). We generated pooled mental health symptom (Cohen ) effect sizes for each service’s clinician-supported and self-directed treatments and compared those with effect sizes we calculated for the alternative treatment programs. Results: The 3 DMHSs offered care to more than 282,000 consumers and therefore contributed to improving overall access to mental health care in Australia. Clinician-supported online treatment significantly improved the mental health of consumers who use these services (Mental Health Online, Cohen =0.95; MindSpot, Cohen =1.42; and THIS WAY UP, Cohen =1.04), and self-directed treatment by Mental Health Online produced a moderate reduction (Cohen =0.59) in anxiety disorder severity ratings. Clinician-supported treatments produced improvements in mental health symptoms that are close or equivalent to most (face-to-face, phone, and stepped or symptom severity–matched mental health care) comparison treatments examined. Conclusions: Mental Health Online, MindSpot, and THIS WAY UP are producing clinically significant improvement for consumers experiencing psychological distress and anxiety and depression symptoms. The magnitude of improvement produced by clinician-supported treatment is comparable with more resource-intensive face-to-face treatment options. Heterogeneity in the magnitude of improvements produced by the 3 DMHSs (and comparator interventions across levels of clinical need) indicates that findings should be interpreted with caution, particularly in relation to the populations for whom DMHSs may be most appropriate.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/ddd844e9a62d6a34e5a9a1339f8c7d62" />
Working with mice, Northwestern scientists have for the first time identified a set of neurons in the brain that play a role in generating anxiety after exposure to cannabinoid drugs, especially under stressful conditions. Cannabinoids are a class of substances that includes tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis and synthetic analogs.
Scientists exposed mice to a predator odor after giving them a placebo or a cannabinoid drug. Animals given the cannabinoid froze more and spent less time investigating the odor. Using small microscopes, scientists identified neurons activated by the drug that helped drive anxious behaviors. When those neurons were silenced the cannabinoid no longer triggered the same level of anxious behaviors.
The findings could help scientists better understand how cannabis exerts its psychoactive effects, and potentially point to strategies for holding back anxiety in affected individuals. The results could provide insights into strategies for reducing anxiety symptoms in other contexts, outside of cannabis use.
“The results of this study could explain why a good trip can turn bad pretty quickly if people consume too much cannabis or the situation they are in turns stressful or scary,” said Sachin Patel, MD, PhD, chair of psychiatry and behavioral sciences at Northwestern University Feinberg School of Medicine.
Patel is senior and corresponding author of the team’s published paper in Nature Communications, titled “Cannabinoid modulation of central amygdala population dynamics during threat investigation.” In their paper the team concluded that their results “… could ultimately provide important insights into how cannabinoids augment threat reactivity and the interactions between cannabis use and anxiety disorders.”
Plant-derived cannabinoids are widely used for medicinal and recreational purposes, and exert broad-ranging behavioral and physiological effects on mood, anxiety, memory, appetite, and sleep, the authors noted. But they can also precipitate anxiety and panic reactions in people, and increase threat-related defensive responses in rodents. “Specifically, while tension and anxiety relief represent major reasons for cannabis use, paradoxical dose- and context-dependent increases in anxiety and panic are also well-documented, and some studies have suggested associations between cannabis use and the development and worsening of anxiety disorders, especially in heavy cannabis users.” However, they continued, Despite well-established research findings, “… how cannabinoids affect in vivo neural dynamics associated with threat-related behavior has not been examined.”
For their newly reported study the scientists exposed mice to a threatening odor. Before being exposed to the scent, derived from fox urine, the mice either received a placebo or a synthetic cannabinoid drug. Patel and colleagues tested several doses of the synthetic cannabinoid on mice and tracked how much time they spent near the predator odor, and whether they froze or fled from the scent.
To simultaneously record brain activity, the team implanted a small microscope into the mice’s brain. The results showed that mice receiving the cannabinoid drug froze more often and spent less time investigating the predator odor. These anxious behaviors were linked to the drug’s activation of a small group of somatostatin neurons (SOM) in the brain’s central amygdala (CeA), a region that processes fear and stress.
Importantly, when the scientists genetically silenced the somatostatin neurons, mice given the cannabinoid drug did not avoid the predator scent as much. The researchers also conducted brain tissue experiments to analyze how the cannabinoids affected interactions between neurons. They found that the drug weakened the brain’s natural “brake” on the somatostatin neurons, allowing them to become more active. “Our data suggest suppression of GABA release from local afferents onto CeA SOM neurons underlies cannabinoid effects on CeA SOM neurons,” they wrote.
![Study authors Drs. Sachin Patel (left) and Farhana Yasmin looking at brain recordings from central amygdala neurons [Gr8y Productions]](https://www.genengnews.com/wp-content/uploads/2026/10/Low-Res_Dr.Patel_50-300x200.jpg)
“Higher doses of cannabinoids and environmental stress worked together to synergistically release the ‘brake’ on the central amygdala, which in turn drove excessive anxiety,” Patel noted. “Understanding how cannabis affects brain function to generate its psychoactive effects could ultimately reveal new ways to counteract negative consequences should they arise in some people,” Patel said, also noting that the findings could have implications beyond cannabis. “Suppressing the activity of somatostatin neurons in the central amygdala could represent a final pathway for reducing anxiety symptoms, not just in the context of cannabis side effects,” he explained.
Cannabis use in the U.S. has steadily increased in recent years and so have emergency department visits related to adverse effects from the drug. Previous studies have also found an association between cannabis use and increased risk of anxiety in the long term. What’s more, anxiety and mood disorders are also on the rise globally.
Commenting that their newly reported data begin to shed light on neural mechanisms subserving the “dark-side” adverse effects of cannabinoids, the authors concluded, “… we suggest cannabinoids could trigger context-dependent adverse anxiety and panic reactions, in part, via activation of CeA-related circuits and that cannabis-induced long-term adaptations in these circuits could contribute to observed associations between cannabis use and anxiety disorders.”
The post Neurons Involved in Generating Anxiety After Cannabinoid Drug Exposure Identified in Mice appeared first on GEN – Genetic Engineering and Biotechnology News.
By Vinay Krishnan
My OCD has always manifested itself through a debilitating fear of harm coming to loved ones and to myself, a subset of OCD called Harm OCD. This showed up most prominently after the September 11th, 2001 attacks in New York. The violent imagery and loss of life stuck to my brain and sparked all sorts of hypothetical violent intrusive thoughts and threats that I’d spend hours imagining every day, to which I would respond with repeated mental and physical reassurances of safety (calming words and affirmations, locking and re-locking the front door). Over the following years, this cycle of obsessions and compulsions would lead to long bouts of depression, of insomnia, and of self-harm. I was 13 on 9/11/2001, I didn’t start medication for my illness until 2012, I didn’t start Exposure and Response Prevention treatment until 2016, and I didn’t find medication that kept me stable until 2020. That is a long long time to go without feeling secure and fully functional. If I knew to see the signs of my illness and if I knew to seek treatment earlier, I could have saved myself over a decade of painful dysfunction and mental torment, and my symptoms would have been far easier to course-correct at an early age than they were later on.
Now, I’m well versed in a variety of tools that keep me safe and healthy. I know to write exposure scripts when my OCD gets intense, I know that mindfulness meditation practices help me process intrusive thoughts without getting stuck to them, and I use a combination of antidepressants and anxiety medications that keep my symptoms far more manageable than they were for most of my life. I’ve told my story in a variety of contexts and mediums–speaking about OCD for NPR, Good Morning America, and as part of the documentary An Unquiet Mind–and I work as a community organizer trying to dismantle some of the systemic barriers that prevent people from accessing and affording the healthcare they need.
Again and again, I remind people still grappling with their OCD symptoms that learning to sit with uncertainty rather than fighting it off is the key to living the life you want with OCD. If folks can learn to do that, they can engage in whatever is most important to them, they can live joyful lives, they can hold stable jobs and provide for their families and do all the things OCD is perhaps telling them is currently impossible to do. I’m 38 now and living a life far beyond any of my expectations or dreams growing up, one filled with joy and companionship and artistry and adventure. That may all feel far-fetched to people growing up with OCD or to people just learning how their OCD works, but there are plenty of tools available now to help folks sit with doubt and gradually loosen OCD’s grip on us. I’m sending everyone some love and strength and lightness on their journey.
While every experience with OCD is different, far too many kids and families face the same barriers to getting answers and effective treatment. See what new IOCDF findings reveal about pediatric OCD care—and what we can do to change it—in Losing Childhood to America’s OCD Care Crisis.
The post If I Only Knew Then — Living with OCD appeared first on International OCD Foundation.